Compare ENTX & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTX | MDV |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 149.6M |
| IPO Year | 2018 | 2022 |
| Metric | ENTX | MDV |
|---|---|---|
| Price | $2.08 | $14.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 77.7K | 33.0K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | ★ 7.85% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $124,000.00 | ★ $47,479,000.00 |
| Revenue This Year | N/A | $0.13 |
| Revenue Next Year | N/A | $0.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 25.25 | N/A |
| 52 Week Low | $1.50 | $13.62 |
| 52 Week High | $3.22 | $17.15 |
| Indicator | ENTX | MDV |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 56.01 |
| Support Level | $2.07 | $14.59 |
| Resistance Level | $2.22 | $15.01 |
| Average True Range (ATR) | 0.15 | 0.30 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 5.42 | 66.67 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.